Cargando…

Targeting cyclin D1 for mantle cell lymphoma

Detalles Bibliográficos
Autor principal:	Chen, Jingtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652500/ http://dx.doi.org/10.1186/2051-1426-3-S2-P430

Ejemplares similares

A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
por: Chen, Jingtao, et al.
Publicado: (2015)

Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma
por: Liu, Hui, et al.
Publicado: (2008)

Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells
por: Body, Simon, et al.
Publicado: (2017)

RNA Inhibition Highlights Cyclin D1 as a Potential Therapeutic Target for Mantle Cell Lymphoma
por: Weinstein, Shiri, et al.
Publicado: (2012)

SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma
por: Narurkar, Roshni, et al.
Publicado: (2016)

Ambra1 modulates the sensitivity of mantle cell lymphoma to palbociclib by regulating cyclin D1
por: Jiang, Zhiping, et al.
Publicado: (2023)

The drive to generate multiple forms of oncogenic cyclin D1 transcripts in mantle cell lymphoma
por: Masamha, Chioniso Patience
Publicado: (2017)

Regulation of cyclin D(1 )by the BRCA1–BARD1 complex
por: Murray, MM, et al.
Publicado: (2008)

Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma
por: Nakamura, Shigeo, et al.
Publicado: (1994)

Potential role of cyclin D(1 )in DNA damage response
por: Suwaki, N, et al.
Publicado: (2006)

Review of the Welsh mammographic screening programme for women who underwent mantle irradiation for Hodgkin lymphoma
por: Edwards, GM, et al.
Publicado: (2012)

P1214: CTPS1 ACTS AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN MANTLE CELL LYMPHOMA
por: Ren, Yi-Min, et al.
Publicado: (2023)

Iron chelation and 2‐oxoglutarate‐dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1
por: Babosova, Olga, et al.
Publicado: (2019)

Protein expression and gene amplification of primary cyclins (A, B(1), D(1), D(3 )and E) and secondary cyclins (C and H) in relation to prognosis in breast cancer patients
por: Husdal, A, et al.
Publicado: (2005)

Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma
por: Krieger, Sophie, et al.
Publicado: (2006)

P1113: PROGNOSTIC ROLE OF GENETIC ABNORMALITIES IN MANTLE CELL LYMPHOMA
por: Kleina, E., et al.
Publicado: (2022)

P1259: CHARACTERIZATION OF VENETOCLAX RESISTANCE IN CELL MODELS OF MANTLE CELL LYMPHOMA
por: Granau, A., et al.
Publicado: (2022)

P1096: TREATMENT PATTERNS AND OUTCOMES IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
por: Bock, A., et al.
Publicado: (2022)

Inhibition of cyclin‐dependent kinase 9 synergistically enhances venetoclax activity in mantle cell lymphoma
por: Zhao, Xiaoxian, et al.
Publicado: (2020)

Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma
por: Mastorci, Katy, et al.
Publicado: (2016)

Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
por: Heine, Simon, et al.
Publicado: (2018)

Hypermethylation of cyclin D(2 )and DAP kinase is associated with the lobular subtype of breast cancer
por: Lehmann, U, et al.
Publicado: (2005)

P1151: METABOLIC TUMOR VOLUME IMPROVES OUTCOME PREDICTION IN UNTREATED MANTLE CELL LYMPHOMA
por: Vergote, V. K., et al.
Publicado: (2022)

Dynamic cyclin profiles as a tool to segregate the cell cycle
por: Munzer, David Garcia, et al.
Publicado: (2013)

P1246: DIFFERENTIAL ROLE OF MICROENVIRONMENT AND STROMAL-CELL INDUCED VENETOCLAX RESISTANCE IN MANTLE CELL LYMPHOMA
por: Andersen, P., et al.
Publicado: (2022)

P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA
por: Kawaji-Kanayama, Yuka, et al.
Publicado: (2023)

P1250: EU-SOX11CCND1: A NOVEL IMMUNOCOMPETENT MURINE MODEL OF MANTLE CELL LYMPHOMA
por: Brown, F., et al.
Publicado: (2022)

Novel targeted therapies for mantle cell lymphoma
por: Alinari, Lapo, et al.
Publicado: (2012)

The Positive Nuclear Staining Observed with Monoclonal Antibody against PRAD1/Cyclin D1 Correlates with mRNA Expression in Mantle Cell Lymphoma
por: Kuroda, Hiroyuki, et al.
Publicado: (1995)

Epigenetic regulation of CD1d-mediated antigen presentation in B cell lymphoma
por: Tiper, Irina, et al.
Publicado: (2014)

Impact of Coronavirus (COVID-19) Pandemic on Maintenance Therapy for Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL)
por: Serna, Angel, et al.
Publicado: (2022)

P1155: BREXUCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ROUTINE PRACTICE: UPDATED REPORT FROM THE US LYMPHOMA CAR T CONSORTIUM
por: Wang, Y., et al.
Publicado: (2022)

P1295: DECIPHERING THE ROLE OF MSI2 AS A REGULATOR OF MANTLE CELL LYMPHOMA STEM-LIKE PROPERTIES
por: Sureda-Gómez, M., et al.
Publicado: (2022)

P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB
por: Le Gouill, S., et al.
Publicado: (2022)

Identification of a novel interaction between the M2 proton channel of influenza A virus and cyclin D3: consequences for cell cycle progression
por: Zhang, Y, et al.
Publicado: (2011)

Rac1 is a novel therapeutic target in mantle cell lymphoma
por: Tian, Tian, et al.
Publicado: (2018)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

Targeting Wnt pathway in mantle cell lymphoma-initiating cells
por: Mathur, Rohit, et al.
Publicado: (2015)

P1089: ZANUBRUTINIB-RITUXIMAB CHEMO-FREE THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA
por: Qu, Chang-Ju, et al.
Publicado: (2023)

P1291: REAL-WORLD DATA OF LONG-TERM SURVIVALS IN PATIENTS WITH MANTLE CELL LYMPHOMA WHO UNDERWENT STEM CELL TRANSPLANTATION
por: Won Baek, Dong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7iji7t4p0a5cfaj7asqbfmf6aa